Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.
To find out more, check out the podcast from which this hour was drawn: “How Are Psychedelics and Other Party Drugs Changing Psychiatry?”
Comments